We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 3,218

A wolf in sheep’s clothing is your litigation settlement anti-competitive?
  • Bryan Cave LLP
  • European Union
  • December 17 2014

As we reported in July 2014, the European Commission fined pharmaceutical company Servier and several of its generic competitors for entering into so

EU: defective products: a potential defect may be sufficient for a finding of liability (CJEU, Boston Scientific Medizintechnik, C-50313 and C-50413)
  • Holman Fenwick Willan LLP
  • European Union
  • March 19 2015

In this case submitted to the CJEU by the German Federal Court, a German company, which sells pacemakers imported from the USA, discovered that these

European infrastructure opportunities - an investment plan for Europe
  • Norton Rose Fulbright LLP
  • European Union
  • December 15 2014

On 26 November 2014, the European Commission announced its investment plan for Europe which is intended to facilitate investments in excess of 315

The EMA adopts a new policy on the publication of clinical data: are IP rights at risk?
  • Martini Manna Avvocati
  • European Union
  • October 30 2014

On 2 October, the European Medicines Agency ("EMA") adopted its new policy on the publication of clinical data for medicinal products for human use

Court of Justice of the European Union asked to rule on SPC expiry dates
  • D Young & Co
  • European Union
  • October 23 2014

The Higher Regional Court of Vienna has recently made a reference to the Court of Justice of the European Union (CJ) requesting a ruling on how to

ECJ: non-fertilised human ovum activated by parthenogenesis could be patentable
  • De Brauw Blackstone Westbroek
  • European Union
  • January 14 2015

The European Court of Justice recently ruled in International Stem Cell Corporation that parthenogenetically activated non-fertilised human ova are

The EMA publishes new biosimilars guideline on non-clinical and clinical issues
  • Hogan Lovells
  • European Union
  • January 15 2015

Following its adoption by the Committee for Medicinal Products for Human Use ("CHMP") on 18 December 2014, the European Medicines Agency ("EMA"

Lupin appeals fine imposed by European Commission in “pay-for-delay” crackdown
  • Patterson Belknap Webb & Tyler LLP
  • European Union
  • December 15 2014

In July of this year, the European Commission imposed fines on French pharmaceutical company Servier and five generic drug makers, including Lupin

Competition news December 2014 (International French)
  • Dentons
  • European Union, France
  • December 24 2014

La Cour d’appel de Paris vient de réformer une décision de l’Autorité de la Concurrence, en considérant que les accords de commercialisation en

Proposed changes to the Eucomed Code
  • CMS Cameron McKenna
  • European Union
  • February 20 2015

Medical device and IVD companies subscribing to the Eucomed or counterpart national business ethics Codes will have to start preparations to cease